• John McMurray is a Professor of Medical Cardiology at the University of Glasgow and Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. 

    Professor McMurray received his MB ChB (Hons) and MD degrees from the University of Manchester. His primary research interests include heart failure, atrial fibrillation, and the cardiovascular consequences of diabetes and chronic kidney disease, with a focus on clinical trials and epidemiology. He has chaired and participated in numerous clinical trial executive/steering and data-monitoring committees and currently chairs the event adjudication group at Glasgow University, which has served as the endpoint committee for many trials.

    Professor McMurray was the lead author of the World Health Organization and first Scottish Intercollegiate Guidelines Network Guidelines on the Management of Heart Failure. In addition, he was a member of the 2008 European Society of Cardiology Heart Failure Guidelines Task Force, Chair of the 2012 Task Force, a member of the 2013 American College of Cardiology/American Heart Association Heart Failure Guidelines Committee, and a member of the 2014 National Institute for Health and Care Excellence (NICE) Acute Heart Failure Guideline Committee. He is a member of the editorial board of the New England Journal of Medicine and sits on the editorial boards of several leading cardiovascular journals, including the European Heart Journal – where he is an Associate Editor – and Circulation. He has published over 750 original papers, reviews, and book chapters (see:  Professor McMurray was included in the 2015 and 2016 listing of Highly Cited Researchers by Thomson-Reuters (see: and He is a member of NICE Appraisal Committee A.

    • Endocrinology, Diabetes and Metabolism
    • Internal Medicine

    I am Professor of Medicine at Yale School of Medicine, where I serve as Program Director of the Endocrine Fellowship, Clinical Chief of Endocrinology, and Medical Director of the Yale Diabetes Center. My clinical practice focuses mainly on diabetes, pituitary and adrenal diseases. My research interests pertain to diabetes and cardiovascular disease.

    • Interventional Cardiology
    • Cardiologist, Director of Cardiometabolic Research and Co-Director at Saint Luke’s Mid America Heart Institute

    Dr. Mikhail Kosiborod is a cardiologist, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. He received training in clinical research, epidemiology and health policy through the Robert Wood Johnson Clinical Scholars Program, as well as clinical training in cardiovascular medicine at Yale University School of Medicine. Dr. Kosiborod is an internationally recognized expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes, as well as quality of care and outcomes. He has authored and co-authored over 200 peer-reviewed publications, including scientific statements and position documents. He is involved in the leadership of multiple clinical trials and multi-center registries, and is currently the principal investigator of several investigator-initiated, multicenter trials in diabetes and cardiovascular disease.

Powered by Medstro